文献速递肝胆胰外科围术期管理与 ERAS

全胰腺切除联合自体胰岛移植对疼痛性慢性胰腺炎的阿片类药物和胰岛素需求疗效:系统评价与荟萃分析

Efficacy of total pancreatectomy with islet autotransplantation on opioid and insulin requirement in painful chronic pancreatitis: A systematic review and meta-analysis.
PubMed 文献 · Surgery · 2019-05-10

本系统评价与荟萃分析纳入15项观察性研究共1255例成人慢性胰腺炎患者,评估全胰腺切除联合自体胰岛移植(TPIAT)对疼痛、内分泌功能和生活质量的影响。结果显示术后1年无阿片类药物率为63%(95%CI 46-77),无胰岛素率为30%(95%CI 20-43),生活质量有统计学改善,但存在发表偏倚。

要点

  • TPIAT可使约三分之二疼痛性难治性慢性胰腺炎患者停用阿片类药物。
  • 术后1年无胰岛素率仅30%,多数患者仍需胰岛素治疗。
  • 酒精病因与TPIAT后无胰岛素率较低相关。

核心结论

  • 在选择的疼痛性难治性慢性胰腺炎患者中,TPIAT对近三分之二患者的疼痛控制有效,但无胰岛素率相对较低。

研究设计与样本

  • 系统评价与荟萃分析,遵循MOOSE指南,检索Cochrane Library、PubMed和Embase(1990年至2018年4月),纳入15项观察性研究共1255例成人患者,使用Newcastle-Ottawa量表评估质量。

主要发现

  • 术后1年无阿片类药物率从0%-15%改善至63%(95%CI 46-77)。
  • 术后1年无胰岛素率从89.5%-100%降至30%(95%CI 20-43)。
  • 酒精病因与TPIAT后无胰岛素率较低相关。
  • TPIAT后生活质量有统计学改善。
  • 阿片类药物和胰岛素结局均存在发表偏倚。

关键数值与推荐

  • 纳入标准:涉及成人慢性胰腺炎行TPIAT的研究;排除标准:未报告疼痛、内分泌功能或生活质量数据的研究。
  • 28%患者曾接受内镜治疗,23%曾接受手术治疗。

临床怎么用

  • 对于选择的疼痛性难治性慢性胰腺炎患者,TPIAT可考虑用于疼痛控制,但需告知多数患者术后仍需胰岛素治疗。

局限性

  • 纳入研究均为观察性研究。
  • 阿片类药物和胰岛素结局均存在发表偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The rationale for total pancreatectomy in painful, treatment refractory, chronic pancreatitis is pain control. Concomitant islet cell autotransplantation can prevent the loss of islet cell function. This study aimed to systematically examine the impact of total pancreatectomy with islet cell autotransplantation on pain and quality of life. METHODS: This meta-analysis was conducted according the Meta-analyses of Observational Studies in Epidemiology guideline. The Cochrane Library, PubMed, and Embase were searched for the following terms (1990 through April 2018): total pancreatectomy and chronic pancreatitis. Studies were included when addressing total pancreatectomy with islet cell autotransplantation for chronic pancreatitis in adults. Studies that reported no data on pain, endocrine function, or quality of life were excluded. Quality was assessed using the Newcastle-Ottawa scale for evaluation of all studies. RESULTS: We included 15 observational studies evaluating 1,255 patients, of whom 28% had had endoscopic and 23% operative therapy. One year after total pancreatectomy with islet cell autotransplantation, the opioid-free rate had improved from between 0% and 15% to 63% (95% CI 46-77), and the insulin-free rate had decreased from between 89.5% and 100% to 30% (95% CI 20-43). An alcoholic etiology was associated with a lesser insulin-free rate after total pancreatectomy with islet cell autotransplantation. Quality of life improved statistically after total pancreatectomy with islet cell autotransplantation. Publication bias was present for both opioid and insulin outcomes. CONCLUSION: In selected patients with painful, treatment refractory, chronic pancreatitis, evidence shows that total pancreatectomy with islet cell autotransplantation is effective for pain control in almost two-thirds of patients, whereas the insulin-free rate is relatively low.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kempeneers MA, Scholten L, Verkade CR, et al. Efficacy of total pancreatectomy with islet autotransplantation on opioid and insulin requirement in painful chronic pancreatitis: A systematic review and meta-analysis. Surgery. 2019. PMID: 31085044. doi:10.1016/j.surg.2019.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。